FDA Drug Recalls

Recalls / Class III

Class IIID-0623-2017

Product

Montelukast sodium tablets, 10 mg, 30-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: HETERO Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-726-30

Brand name
Montelukast Sodium
Generic name
Montelukast Sodium
Active ingredient
Montelukast Sodium
Route
Oral
NDC
31722-726
FDA application
ANDA202843
Affected lot / code info
Lot # MON16001B, Exp 01/18

Why it was recalled

Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle.

Recalling firm

Firm
Hetero USA Inc
Manufacturer
Camber Pharmaceuticals, Inc.
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
1035 Centennial Ave, Piscataway, New Jersey 08854-4124

Distribution

Quantity
65,664 bottles
Distribution pattern
US Nationwide

Timeline

Recall initiated
2017-01-07
FDA classified
2017-03-29
Posted by FDA
2017-04-05
Terminated
2017-08-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0623-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Montelukast Sodium · FDA Drug Recalls